Publications by authors named "A Flament"

Claim this Profile
D
Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia.
Daniel Pollyea, Tessa Kerre, Dries Deeren, Yves Beguin, Tara L Lin, Anne Flament

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the potential of PubMed Central supplementary data files.
Julien Gobeill, Déborah Caucheteur, Alexandre Flament, Pierre-André Michel, Anaïs Mottaz

Bioinform Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells.
Caroline Lonez, Jennifer Bolsée, Fanny Huberty, Thuy Nguyen, Céline Jacques-Hespel, Anne Flament

Int J Mol Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viscosity of Suspensions of Strongly Bonded Spherical Particles of Nickel-Manganese-Cobalt Mixed Oxides (NMC) in Molten Poly(Ethylene Carbonate) for Batteries.
Augustin Flament, Melinda Desse, Pierre Bernard, Christian Carrot

Macromol Rapid Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial.
David A Sallman, Tessa Kerre, Violaine Havelange, Xavier Poiré, Philippe Lewalle, Anne Flament

Lancet Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis